Artificial Intelligence
Proscia: Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images CAMBRIDGE, Mass. and PHILADELPHIA – February 27, 2024 – Proscia®, a leading provider of digital and computational pathology...
From the Medriva Blog Revolutionizing Digital Pathology with Deep Learning In the rapidly evolving landscape of healthcare and medicine, artificial intelligence (AI) and deep learning (DL) techniques are emerging as transformative tools,...
Lunit: A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint...
Proscia Ready advances increasingly comprehensive approach for realizing the full promise of digitization PHILADELPHIA – February 20, 2024 –Proscia®, a leading provider of digital and computational pathology solutions, has established a...
From Pathology News: by Christos Evangelou, MSc, PhD – Medical Writer and Editor Accurate identification of cell types and extraction of morphological features from histopathological images is crucial for understanding disease processes...
SEOUL, SOUTH KOREA, February 5, 2024 /EINPresswire.com/ -- Deep Bio, a pioneer of AI-powered cancer diagnostics solutions, proudly announced the inclusion of DeepDx Prostate in CancerX's Solutions Catalog. This significant participation...
